
Sign up to save your podcasts
Or


Leslie O’Dell, OD, FAAO, and Jackie Garlich, OD, FAAO, welcome Tom Kislan, OD, to discuss Tyrvaya (Oyster Point Pharma)—an FDA-approved nasal spray for dry eye treatment. Together, they discuss the link between neural stimulation and basal tear production, patient selection for Tyrvaya, patient education on product use within the clinic, and more.
By Modern Optometry5
1515 ratings
Leslie O’Dell, OD, FAAO, and Jackie Garlich, OD, FAAO, welcome Tom Kislan, OD, to discuss Tyrvaya (Oyster Point Pharma)—an FDA-approved nasal spray for dry eye treatment. Together, they discuss the link between neural stimulation and basal tear production, patient selection for Tyrvaya, patient education on product use within the clinic, and more.

77 Listeners

1,143 Listeners

9,280 Listeners

8,190 Listeners

63 Listeners

81 Listeners

521 Listeners

5 Listeners

19 Listeners

20 Listeners

802 Listeners

21 Listeners

364 Listeners

18 Listeners

18 Listeners